Aurinia Pharmaceuticals Inc
AUPH
|
|
| |
|
| Trading Volume | 43,224 |
|
|
10.19 - 4.81 |
| Market Cap Full | $ 1B |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | -5.1% | -44.3% | 153.7% | -45.9% |
| Q2 | - | 3.9% | -11.7% | -18.8% |
| Q3 | - | 17.3% | -19.7% | -25.2% |
| Q4 | - | -1.6% | 20.8% | -42.6% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -5.1 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -16.1 | -24.1 | -12.4 | -0.4 | 8.6 | 3.7 | 4.6 | 17.3 | - | - | - | - |
| 2023 | |||||||||||
| 109.5 | 0.4 | 20.6 | 2.7 | -20.4 | 8 | 19.6 | -21.7 | -14.3 | -5.5 | 17.7 | 4.1 |
| 2022 | |||||||||||
| -27.2 | -25.7 | - | -14.4 | 6.4 | -10.9 | -18.6 | -9.4 | 1.5 | 8.1 | -36.9 | -15.8 |
| 2021 | |||||||||||
| 23.2 | -16.2 | -7.3 | 2.2 | 9.5 | -10.8 | 4.6 | 20.1 | 35.9 | 49.5 | -46.5 | 29.2 |
| 2020 | |||||||||||
| -11.4 | -4.6 | -15.7 | 18.8 | -8 | 2.4 | -13.1 | 5 | -1.1 | 6.1 | -5.8 | -7.6 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.2 | -0.3 | -0.4 | -0.2 |
| Q2 | -0.1 | -0.3 | -0.4 | -0.3 |
| Q3 | -0.1 | -0.1 | -0.4 | -0.3 |
| Q4 | 0 | -0.2 | -0.2 | -0.1 |
| A | -0.35 | -0.8 | -1.4 | -0.9 |